Gliknik is making new therapies for patients with cancer and autoimmune/inflammatory diseases. Our expertise is modulation of the immune system.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 09/01/09 | Series A | 1.1M | Unknown |
People
David Block (CEO, President)
News
Life sciences briefing: Tuesday, Nov. 20, 2007
November 20, 2007 3:09 pm
Featured companies: American TeleCare, Gliknik, Juvaris BioTherapeutics, Medsphere Systems, Primera Biosystems UPDATED: Expanded items on Juvaris, Medsphere, Primera, American TeleCare… Continue reading ⟩